// App-Quantinova.ai

e17048 : Evaluating a novel oncologist-led BRCA1/2 mutation (BRCAm) testing counseling model for patients with ovarian cancer: Interim results from the ENGAGE study.

Researchers

Presenter

  • Gloria S. Huang

Principal Investigators

  • Ilian Tchakov

  • Yann Bourhis

  • Giovanni Scambia

  • Ettore Capoluongo

  • Begona Grana-Suarez

  • Jose Antonio Lopez-Guerrero

  • Andres Poveda

  • Sudeep Karve

  • Danielle Potter

  • David Lawrence

  • Jerzy E. Tyczynski

  • Eva Chalas

Medical Centers

  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

  • Mapi SAS, Lyon, France

  • Universita Cattolica del Sacro Cuore di Roma, Unita di Ginecologia Oncologica UOC, Rome, Italy

  • Universita Cattolica del Sacro Cuore di Roma and Foundation Hospital A. Gemilli, UOS Diagnostica Molecolare Clinica, Rome, Italy

  • Complexo Hospitalario Universitario A Coruna, Galicia, Spain

  • Laboratorio de Biologia Molecular, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain

  • Clinical Area of Gynecologic Oncology, Instituto Valenciano de Oncologia (IVO), Valencia, Spain

  • AstraZeneca, Gaithersburg, MD

  • Winthrop-University Hospital, Mineola, NY

Locations

  • Italy

  • Spain

  • United Kingdom

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Peritoneal cancer

  • Gynaecological cancer

Biomarkers

  • Alpha-tubulin N-acetyltransferase 1

  • Breast cancer type 1 susceptibility protein

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • NCT02406235

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved